MDT - Medtronic PLC - Stock Price & Dividends

Exchange: USA Stocks • Country: Ireland • Currency: USD • Type: Common Stock • ISIN: IE00BTN1Y115

Cardiac Devices, Neurological Implants, Surgical Instruments, Insulin Pumps

Medtronic plc is a global leader in developing, manufacturing, and selling innovative medical devices and therapies that improve the lives of millions of people worldwide. The company's Cardiovascular Portfolio segment is dedicated to providing life-changing solutions for heart patients, including implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices. Additionally, they offer a range of products for cardiac ablation, insertable cardiac monitoring, and remote patient monitoring, as well as aortic valves, surgical valve replacement and repair products, and transcatheter pulmonary valves.

The Neuroscience Portfolio segment focuses on providing medical devices and implants, biologic solutions, and interventional products for a wide range of medical specialties, including spinal surgeons, neurosurgeons, neurologists, pain management specialists, and orthopedic surgeons. Their products include spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and nerve ablation systems, as well as energy surgical instruments.

The Medical Surgical Portfolio segment offers a broad range of surgical solutions, including surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, and AI-powered surgical video and analytics platforms. They also provide robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, and gastrointestinal and hepatologic diagnostics and therapies. Furthermore, they offer patient monitoring and airway management products to support healthcare professionals in providing high-quality care.

The Diabetes Operating Unit segment is dedicated to improving the lives of people with diabetes, offering innovative products such as insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. With a rich history dating back to 1949, Medtronic plc is headquartered in Galway, Ireland, and continues to drive innovation and advancements in medical technology. To learn more, visit their website at https://www.medtronic.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for MDT - Medtronic PLC  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for MDT - Medtronic PLC  - Stock Price & Dividends

MDT Stock Overview

Market Cap in USD 115,165m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception 1978-01-13

MDT Stock Ratings

Growth 5y -13.7
Fundamental 28.1
Dividend 60.1
Rel. Performance vs Sector 0.80
Analysts 3.76/5
Fair Price Momentum 98.85 USD
Fair Price DCF 100.07 USD

MDT Dividends

Dividend Yield 12m 3.09%
Yield on Cost 5y 2.96%
Dividends CAGR 5y 5.34%
Payout Consistency 97.8%

MDT Growth Ratios

Growth Correlation 3m 70.5%
Growth Correlation 12m 51.8%
Growth Correlation 5y -55.3%
CAGR 5y -1.29%
CAGR/Mean DD 5y -0.06
Sharpe Ratio 12m 1.30
Alpha vs SP500 12m -5.66
Beta vs SP500 5y weekly 0.90
ValueRay RSI 29.43
Volatility GJR Garch 1y 17.50%
Price / SMA 50 -1.43%
Price / SMA 200 5.66%
Current Volume 7077.4k
Average Volume 20d 5162.5k

External Links for MDT Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of MDT stocks?
As of November 08, 2024, the stock is trading at USD 88.12 with a total of 7,077,445 shares traded.
Over the past week, the price has changed by -1.27%, over one month by +1.24%, over three months by +9.53% and over the past year by +25.70%.
What are the forecast for MDT stock price target?
According to ValueRays Forecast Model, MDT Medtronic PLC will be worth about 108 in November 2025. The stock is currently trading at 88.12. This means that the stock has a potential upside of +22.58%.
Issuer Forecast Upside
Wallstreet Target Price 95.6 8.52
Analysts Target Price 90.4 2.63
ValueRay Target Price 108 22.6